Medscape Medical NewsAll articles

Arterys Cardio DL

ARTERYS INC. • Radiology • 01/05/2017

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

Arterys Cardio DL is a web-accessible software tool designed to enhance clinical decision-making by providing advanced post-processing, visualization, and quantification of cardiovascular MR images. It employs manual and semi-automatic segmentation on multi-parametric MR data, including 4D Flow, to generate reproducible quantitative metrics of cardiac structure, function, and blood flow dynamics for pediatric and adult patients.

Summary

Arterys Cardio DL is a web-accessible software device designed for the post-processing analysis of cardiovascular Magnetic Resonance (MR) images. Its primary purpose is to assist qualified healthcare professionals by enabling the visualization and quantification of cardiac structures and blood flow from DICOM-compliant MR data. The software utilizes manual and semi-automatic border detection techniques to analyze multi-slice, multi-phase, and velocity-encoded MR images acquired from both 1.5T and 3.0T scanners. It supports various workflows, including Basic 2D, Basic 3D, 4D Flow, and 2D Phase Contrast, and is intended for use with both pediatric (neonate, infant, child, adolescent) and adult patient populations, providing tools for loading, saving, displaying, and aggregating quantitative data. The software offers comprehensive image visualization functionalities, including 2D and 3D review options (MIP, Surface MinIP, Surface, Average), multi-planar reconstruction (MPR), cine playback, and dedicated cardiac views. Quantitatively, Arterys Cardio DL performs anatomy and tissue segmentation, measures distances and areas, and assesses a range of cardiac function parameters such as stroke volume, ejection fraction, cardiac output, and end-diastolic/systolic mass and volume. It also provides advanced flow quantification capabilities, including net, forward, and reverse flow, regurgitation fraction, pressure gradients, primary flow direction, and phase error correction, along with directional vector display of blood particle travel and valve flow analysis. The data and annotated images produced are displayed within a web browser, can be saved for later use, or sent to a Picture Archiving and Communication System (PACS) to support clinical decision-making, acting as a support tool rather than a primary source for medical advice or treatment determination.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

Cardiovascular MRImage Post-processingQuantitative AnalysisBlood Flow QuantificationDICOM4D FlowCardiac FunctionImage VisualizationSemi-automatic SegmentationClinical Decision Support

Device Metadata

Submission Number
K163253
Company
ARTERYS INC.
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Analysis
AI Subclass
quantification/feature localization

Relevant Clinical Questions

  • Q1. What are the specific performance metrics (e.g., accuracy, reproducibility, inter-observer variability) for the semi-automatic segmentation algorithms, particularly for complex cardiac anatomies or pathologies?; How does the 4D Flow quantification algorithm account for potential artifacts or noise inherent in velocity-encoded MR sequences, and what are its validated limits of detection for low-flow states or turbulent flow?; What is the typical processing time required for a full 4D Flow analysis on a standard cardiac MR dataset, and how does this compare to other commercially available solutions or manual analysis?; Are there any known limitations or contraindications for using Arterys Cardio DL with specific patient populations (e.g., patients with arrhythmias, congenital heart defects) or certain MR scanner hardware/software configurations beyond the stated 1.5T and 3.0T compatibility?; How does the software handle phase error correction, and what is the impact of this correction on the accuracy of derived flow parameters like regurgitant fraction or pressure gradients?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score20/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan⚠ Not mentioned in summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(algorithm, dataset)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(server)
✓ Detected
HBOMHardware Bill of Materials(hardware)
✓ Detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials(configuration)
✓ Detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM, HBOM, OBOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, CBOM, VDR/VEX. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
Arterys Cardio DL - ARTERYS INC. | ESL FDA AI Device Intelligence